1.Molecular study of HCV detection, genotypes and their routes of transmission in North West Frontier Province, Pakistan
Safi Zaman Sher ; Waheed Yasir ; Sadat Joharia ; Salahuddin Sadia ; Saeed Umar ; Ashraf Muhammad
Asian Pacific Journal of Tropical Biomedicine 2012;(7):532-536
Objective: To determine hepatitis C virus (HCV) genotypes and explore the associated risk factors in chronic HCV patients. Methods:A total of 116 patients with chronic hepatitis C were subjected to polymerase chain reaction (PCR) based detection out of which 112 chronic HCV patients [53 male (47.32%), 59 female (52.68%);mean age (43.76±16.40) years;mean BMI (23.8±3.9) kg] were enrolled in this study. The frequency of 6 HCV genotypes and associated risk factors were evaluated from five districts of North West Frontier Province (NWFP). Results:Genotype 3 was the most prevalent in 73 samples (65.17%) followed by genotype 1 in 24 (21.42%) and genotype 2 in 13 (11.60%) samples. Genotype 3 had significantly high prevalence (P=0.000 2). The results showed that 48 (42.85%) samples were infected with HCV 3a;25 (22.32%) with 3b;14 (12.50%) with 1a;10 (8.92%) with 1b; 11 (9.82%) with 2a; 2 (1.78%) with 2b;and 2 were untypable. The distribution of HCV genotypes in Mardan, Charsadda, Peshawar, Sawabi and Nowshehra districts was different. Use of unsterile equipment for medication, barbers and previous history of hospitalization were the main risk factors for HCV transmission. Conclusions:Genotype 3a and 3b, 1a, 1b and 2a are the common genotypes in NWFP. Genotype 4, 5, and 6 can not be found in a single sample. The level of awareness about various modes of transmission of HCV among the population is found to be very low.
2.Optogenetics Applications for Treating Spinal Cord Injury.
Aftab AHMAD ; Sadia ASHRAF ; Shoji KOMAI
Asian Spine Journal 2015;9(2):299-305
Cases of spinal cord injury (SCI) are increasing all over the world; and in USA alone, there are 273,000 patients, which not only leads to morbidity and mortality but also results in a great economic burden. Many approaches are being used at the pre-clinical and clinical level to treat SCI including therapeutic agents, surgical decompression, stem cell therapy etc. Recently, a new approach called optogenetics has emerged in which light sensitive proteins are used to switch neurons on and off, and this approach has great potential to be used as therapy due to its specificity and rapid response in milliseconds. Few animal studies have been performed so far in which the respiratory and bladder function of rats was restored through the use of optogenetics. On the basis of promising results obtained, in the future, this approach can prove to be a valuable tool to treat patients with SCI.
Animals
;
Decompression, Surgical
;
Humans
;
Mortality
;
Neurons
;
Optogenetics*
;
Rats
;
Regeneration
;
Sensitivity and Specificity
;
Spinal Cord Injuries*
;
Stem Cells
;
Urinary Bladder
3. Viral hepatitis in Pakistan: Challenges and priorities
Asian Pacific Journal of Tropical Biomedicine 2015;5(3):190-191
Hepatitis B and C are big health issues worldwide as more than 400 million people are suffering from chronic hepatitis B and C which result in more than 1.4 million deaths each year. According to a study done by Pakistan Medical Research Council in 2007-08, 7.6% Pakistani population suffered with hepatitis B and C, with around 4.8% with hepatitis C only. Government of Pakistan has taken different initiatives like vaccination, patient safety, blood screening, education and awareness about disease but still there is high prevalence of hepatitis in Pakistan. According to some studies injecting drug users have the highest prevalence of hepatitis B and C in the country. The follow-up studies and documentation of hepatitis patients was not very good which need to be improved. There is no recent large scale study on risk factors and prevalence of hepatitis B and C in Pakistan so it should be done on an urgent basis. If government set up regional laboratories for prevalence study and also a central institute for hepatitis research and treatment, the disease could be prevented in better and proper way. The treatment of hepatitis is very costly and a developing country like Pakistan cannot afford such high costs. Therefore more focus should be on preventive measures.
4.Stem Cell Research in Pakistan; Past, Present and Future.
Sayeda Anum ZAHRA ; Sayed Raheel MUZAVIR ; Sadia ASHRAF ; Aftab AHMAD
International Journal of Stem Cells 2015;8(1):1-8
BACKGROUND AND OBJECTIVES: Stem cells have proved to have great therapeutic potential as stem cell treatment is replacing traditional ways of treatment in different disorders like cancer, aplastic anemia, stroke, heart disorders. The developed and developing countries are investing differently in this area of research so research output and clinical translation of research greatly vary among developed and developing countries. Present study was done to investigate the current status of stem cells research in Pakistan and ways to improve it. RESULTS: Many advanced countries (USA, UK and Canada etc.) are investing heavily in stem cell research and treatment. Different developing countries like Iran, Turkey and India are also following the developed countries and investing a lot in stem cells research. Pakistan is also making efforts in establishing this field to get desired benefits but unfortunately the progress is at very low pace. If Government plays an active role along with private sector, stem cell research in Pakistan can be boosted up. The numbers of publications from Pakistan are very less compared to developed and neighboring countries and Pakistan also has very less number of institutes working in this area of research. CONCLUSIONS: Stem cells research is at its initial stages in Pakistan and there is great need to bring Government, academia and industry together so they could make serious efforts to promote research in this very important field. This will help millions of patients suffering from incurable disorders and will also reduce economic loss.
Academies and Institutes
;
Anemia, Aplastic
;
Canada
;
Developed Countries
;
Developing Countries
;
Heart
;
Humans
;
India
;
Iran
;
Pakistan*
;
Private Sector
;
Stem Cell Research*
;
Stem Cells
;
Stroke
;
Turkey